LPMAF - Performance: Lymphocyte Proliferation Panel for Mitogens and Antigens

Test Catalog

Test ID: LPMAF    
Lymphocyte Proliferation Panel for Mitogens and Antigens

Method Description Describes how the test is performed and provides a method-specific reference

Lymphocyte Proliferation to Mitogens, Blood:

Peripheral blood mononuclear cells in RPMI 1640 medium supplemented with L-glutamine and 5% human AB serum are incubated unstimulated or stimulated with varying concentrations of pokeweed (PWM)- and phytohemagglutinin. A daily experimental normal control is included with each batch of patient samples to serve as an internal control.

 

Following incubation, the cells are assessed for proliferation and stained with the following markers: CD45+ lymphocytes, CD3+ T cells, CD69+ activated cells, and CD19+ B cells (PWM only). Results are reported for the percent viable cells on day 0, as well as the percentage of proliferating cells of total lymphocytes, T cells, and B cells (PWM only).(Package insert: 4, Invitrogen Click-iT-EdU; unpublished Mayo method)

 

Lymphocyte Proliferation to Antigens, Blood:

Peripheral blood mononuclear cells in RPMI 1640 medium supplemented with L-glutamine and 20% human AB serum are incubated unstimulated or stimulated with varying concentrations of candida albicans (CA)- and tetanus toxoid (TT). A daily experimental normal control is included with each batch of patient samples to serve as an internal control.

 

Following incubation, the cells are assessed for proliferation and stained with the following markers: CD45+ lymphocytes, CD3+ T cells, and CD69+ activated cells. Results are reported for the percent viable cells on day 0, as well as the percentage of proliferating cells of total lymphocytes and T cells.(Package insert: 4, Invitrogen Click-iT-EdU; unpublished Mayo method)

PDF Report Indicates whether the report includes an additional document with charts, images or other enriched information

No

Day(s) and Time(s) Test Performed Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.

Monday through Friday

Do not send specimen after Thursday.

Analytic Time Defines the amount of time it takes the laboratory to setup and perform the test. This is defined in number of days. The shortest interval of time expressed is "same day/1 day," which means the results may be available the same day that the sample is received in the testing laboratory. One day means results are available 1 day after the sample is received in the laboratory.

8 days for LPMGF and 11 days for LPAGF

Maximum Laboratory Time Defines the maximum time from specimen receipt at Mayo Medical Laboratories until the release of the test result

11 days for LPMGF and 14 days for LPAGF

Specimen Retention Time Outlines the length of time after testing that a specimen is kept in the laboratory before it is discarded

No specimen retention Entire specimen is used in preparation of the assay

Performing Laboratory Location The location of the laboratory that performs the test

Rochester
Tell Us What You Think